Trusted by:
A quiet night of quality, restful sleep and dreaming can help both depressed and non-depressed individuals work out their negative feelings and problems, according to sleep researchers at Rush-Presbyterian-St. Luke's Medical Center, Chicago, who conducted two long-term comprehensive studies of how dreams and sleep restore psychological balance after a "bad day."
A monoclonal antibody may allow more patients withh a common type of leukemia to use their own bone marrow to treat the disease and prolong their disease-free survival. An in-vivo purging process using Rituxan rids blood stem cells of leukemia in autologous transplants.
An important indicator of a more aggressive form of breast cancer appears to be present in less aggressive breast cancers in many women who have used hormone replacment therapy, according to researchers at Rush-Presbyterian-St. Luke's Medical Center, Chicago.
Heart attack patients who received an new intravenous adult stem cell therapy, Provacelâ„¢, experienced a lower number of adverse events, such as cardiac arrhythmias, and had significant improvements in heart, lung and global function compared to those who received a placebo, according to six-month Phase I study data presented at the American College of Cardiology's Innovation in Intervention: i2Summit in New Orleans on March 25.
For the first time in a large-scale study, transcranial magnetic stimulation has been shown to be an effective, non-drug treatment for major depression. Current antidepressant therapies are not beneficial for at least a third of depressed individuals, leaving many with a lack of adequate treatment options. This study will be published in the December 1st issue of Biological Psychiatry
Researchers have successfully used a peptide to reverse biochemical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD), and report success in preventing the disease from progression.
Findings from two large, international clinical trials show "unprecedented" survival for patients with multiple myeloma, a blood cancer that occurs in the blood-making cells of bone marrow. The findings demonstrate that with Revlimid, an oral cancer drug, all measures of myeloma showed significant improvement in patients where previous treatments had failed. Rush University Medical Center took part in the U.S. study. Results of the study were published November 21 in the New England Journal of Medicine.
Moderate, long-term pain medication use does not impair a person's ability to drive safely, according to a study by Dr. Asokumar Buvanendran, associate professor, Department of Anesthesiology at Rush University Medical Center, Chicago. The study was presented at the American Society of Anesthesiologists meeting in San Francisco on October 13.
The drug pregabalin administered before and after knee replacement surgery, significantly decreased patient pain while increasing and expediting mobility after surgery, according to a study by Asokumar Buvanendran, MD, director of Orthopedic Anesthesia and associate professor of Anesthesiology at Rush University Medical Center, Chicago.
A research study by orthopedic spine, back and neck surgeon at Rush University Medical Center Dr. Howard An and colleagues found that patients who underwent surgery for spinal stenosis showed significantly more improvement in all primary outcomes than did patients who were treated nonsurgically. The study findings were published in the New England Journal of Medicine, February 21.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right